microdosing glp 1 alzheimer's Semaglutide ameliorates disease and restores oxytocin in APP/PS1 mice and human brain organoid models So… do weight loss drugs

Understanding how these medications interact with gut physiology can help patients make informed decisions about their digestive health

Because autonomic disorders affect multiple organ systems, the presentation of symptoms are heterogenous, widely varying between different individuals

The intestinal microbiota is a large and vital ecosystem in the human body and is considered to be the equivalent of an organ of the human body, which is highly relevant to human health and disease status

The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome

Type 2 diabetes with cardiovascular or kidney risk Obesity or overweight with comorbidities, where meaningful weight loss would change your risk Obesity-related OSA or knee osteoarthritis where GLP-1s can treat upstream weight and symptoms Have we done the foundations